Home/Pipeline/Sirolimus-Coated Balloon (SCB) - MAGICAL ISR

Sirolimus-Coated Balloon (SCB) - MAGICAL ISR

Coronary In-Stent Restenosis (ISR)

Phase 3 (IDE)Ongoing

Key Facts

Indication

Coronary In-Stent Restenosis (ISR)

Phase

Phase 3 (IDE)

Status

Ongoing

Company

Concept Medical

About Concept Medical

Headquartered in Tampa, Florida, Concept Medical is a leader in developing innovative solutions for cardiovascular diseases, focusing on unmet clinical needs in coronary and peripheral artery disease. The company's mission, 'Converting Concepts into Reality,' is powered by its patented Nanolute, Nanoactive, and Envisolution technologies. With a vast clinical trial portfolio including the world's largest RCT on diabetic patients and multiple ongoing IDE studies in the US, Concept Medical is positioned at the forefront of the drug-coated balloon and stent market.

View full company profile

Therapeutic Areas

Cardiovascular Peripheral Vascular Disease Coronary Artery Disease

Other Coronary In-Stent Restenosis (ISR) Drugs

Drug	Company	Phase	Status
Virtue® Sirolimus AngioInfusion™ Balloon (SAB)	Orchestra BioMed	Late-Stage Clinical (Pivotal)	Investigational; Breakthrough Device Designation; Leveraging existing data for pivotal study